![]() |
市场调查报告书
商品编码
1827754
2025年全球医用人工材料市场报告Medical Engineered Materials Global Market Report 2025 |
近年来,医疗义肢材料市场快速扩张,市场规模将从2024年的221.2亿美元成长至2025年的252.4亿美元,复合年增长率为14.1%。预测期内的成长归因于人口老化、法规遵循、感染控制、植入材料和组织工程。
预计未来几年医疗义肢材料市场将快速成长,到2029年将达到431.8亿美元,年复合成长率(CAGR)为14.4%。预测期内的成长可归因于全球卫生防备、3D列印和积层製造、先进涂层、奈米医学和个人化医疗。预测期内的主要趋势包括奈米技术、可生物降解和可吸收材料、生物活性智慧材料、永续性和环保材料以及医疗技术的进步。
医学工程材料,通常称为生物材料,是经过特殊设计的物质,旨在满足特定或客製化的标准,与生物系统相互作用,用于医疗领域的治疗或诊断。这些材料在科学、技术和医学的交叉领域中发挥关键作用,其应用将材料科学的关键要素与对医学设计的深刻理解相结合。
医疗工程材料的主要类别包括医用塑胶、医用泡棉、医用薄膜、医用黏合剂和医用弹性体。医用级塑胶材料用于製造医疗用品。这些材料用于製造体外诊断产品和药品的初级包装,确保药品的保存和密封,防止污染。应用范围包括医疗设备、一次性医疗用品、医用穿戴式装置和进阶伤口护理。
2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响,尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价,製造商面临利润压力。监管挑战使情况更加复杂,因为由于关税而更换供应商通常需要重新认证医疗设备,导致市场进入延迟。为此,企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。
本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分,该系列提供医疗义肢材料市场统计数据,例如全球市场规模、区域份额、竞争对手的市场份额、详细的医疗义肢材料细分市场、市场趋势和商机,以及您在医疗义肢材料行业取得成功所需的数据。本医疗义肢材料市场研究报告对该行业的现状和未来趋势进行了详细分析,为您提供所需的一切观点。
我们预测未来五年该市场将成长14.4%,较我们先前对该市场的预测略有下降0.2%。下降的主要原因是美国与其他国家之间关税的影响。美国对瑞士生物相容性钛和聚醚醚酮 (PEEK) 聚合物征收的关税上调,直接影响了美国,并可能减缓植入和假体的生产,同时推高医疗成本。此外,由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响,这种影响也将更加广泛地显现。
慢性病的预期成长将推动医疗义肢材料市场的成长。慢性病的特征是病程长达一年以上,需要持续治疗,且日常活动受限,这推动了对奈米级设计材料的需求。奈米工程组件可用于建构心腔的微型复製品,为治疗心臟相关疾病提供创新解决方案。根据美国国家生物技术资讯中心 (NCBI) 2023 年 1 月的报告,预计到 2050 年,全球慢性病患者人数将达到 1.4266 亿,较 2020 年的 7152.2 万人大幅增加。慢性病的增加将成为医疗义肢材料市场成长的催化剂。
预计外科手术数量的增加将推动医疗义肢材料市场的成长。外科手术是指需要切口或侵入性技术来进入和治疗身体内部或外部区域的医疗干预措施。外科手术数量的激增推动了对手术器械、植入式器械以及微创手术所用材料的需求。对生物相容性和抗感染材料的迫切需求凸显了它们在确保病人安全方面的关键作用。由客製化和监管标准驱动的研发,以及由成本效益和技术进步驱动的材料创新,正在推动医疗义肢材料市场的成长。例如,经济合作暨发展组织)在 2023 年 10 月报告称,捷克共和国的白内障手术数量将从 2021 年的 131,612 例增加 8.4%,到 2022 年将达到 142,670 例。因此,外科手术数量的增加将成为医疗义肢材料市场的成长动力。
医疗义肢材料市场的主要企业正在策略性地推出新产品,以增强其竞争地位。例如,美国特种材料公司塞拉尼斯公司于2022年5月推出了Celanex MT PBT 2406MT GF20。这款高性能材料专为医疗设备和各种应用而设计,具有卓越的强度、刚性和无噪音的滑动性能。其应用范围包括I类、II类和III类医疗设备,以及汽车、电气和电子设备、工业机械和消费品。这款摩擦改质PBT+PET牌号,采用20%的玻璃纤维增强,可为各行各业提供多功能解决方案。
医疗义肢材料市场的主要企业正在投资新产品开发,以获得竞争优势。总部位于德国的聚合物材料公司科思创股份公司于2023年2月推出了Makrolon 3638聚碳酸酯。这款先进的材料解决方案专为医疗保健和生命科学应用量身定制,在从低温到蒸气灭菌的广泛温度范围内均具有高耐久性。它具有高抗衝击强度、延展性和耐化学性,符合医疗级和生物相容性标准。该材料适用于皮肤接触应用,也具有食品接触级质量,并可使用医疗保健领域常用的方法进行灭菌。
2022年2月,总部位于美国的全球工业领导者塞拉尼斯公司以110亿美元完成了对杜邦树脂和先进解决方案业务线的收购。这项战略倡议预计将使塞拉尼斯凭藉其无与伦比的规模、生产能力和技术专长,成为汽车、消费品和工业市场的市场领导。杜邦是一家从事医疗工程材料业务的美国公司,也参与了这项收购。
医疗工程材料市场的主要企业包括赢创工业股份公司、科思创股份公司、BASF股份公司、索尔维股份公司、沙乌地基础工业公司、特瑞堡股份公司、荷兰皇家帝斯曼集团、塞拉尼斯公司、杜邦公司、爱惜康公司、汉高股份公司、亨斯迈公司、迈图高新材料公司、日电工株公司、Recticel 公司、亨斯迈公司、迈图高新材料公司、日电工株式公司、Recticel 有限公司、Peusel 公司、Peus、TRT 公司、Peusel 公司、Peusel 公司工业产品公司、圣戈班公司、阿科玛公司、伊士曼化学公司、路博润公司、普立万公司、Quadrant 股份公司、Rochling 集团、帝斯曼生物医学、Invibio 有限公司、卡彭特技术公司、Heraezol 公司、卡彭特技术公司、卡彭特技术公司、弗利氏医疗组件、Ceramezol 公司、卡彭特技术公司、卡彭特技术公司、弗利氏医疗组件Inc.、美敦力公司、雅培实验室、强生公司和西门子医疗股份公司。
2024年,亚太地区是医疗义肢材料市场最大的地区。预计亚太地区将成为预测期内成长最快的地区。本医疗义肢材料市场分析报告涵盖亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。
医用人工材料市场报告涉及的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国和美国。
医用义肢材料市场涵盖医用塑胶、医用泡棉、医用薄膜、医用弹性体和医用黏合剂的销售。该市场的价值指的是“出厂价”,即商品製造商或生产商销售给其他营业单位(包括下游製造商、批发商、经销商和零售商)或直接销售给最终客户的价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。
Medical engineered materials, often referred to as biomaterials, denote substances that are specifically crafted to meet particular or customized criteria, aiming to interact with biological systems for therapeutic or diagnostic purposes in the field of medicine. Serving as a crucial link between science, technology, and medicine, these materials are employed to integrate essential elements of materials science with a deep understanding of medical design.
The principal categories of medical engineered materials include medical plastics, medical foams, medical films, medical adhesives, and medical elastomers. Medical-grade plastic materials are formulated to produce items for medical applications. These materials find use in the manufacturing of products for in vitro diagnostics and primary packaging for pharmaceuticals, ensuring the preservation and containment of medicines to prevent contamination. The diverse applications span medical devices, medical disposables, medical wearables, and advanced wound care.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The medical engineered materials market research report is one of a series of new reports from The Business Research Company that provides medical engineered materials market statistics, including medical engineered materials industry global market size, regional shares, competitors with a medical engineered materials market share, detailed medical engineered materials market segments, market trends and opportunities, and any further data you may need to thrive in the medical engineered materials industry. This medical engineered materials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The medical engineered materials market size has grown rapidly in recent years. It will grow from $22.12 billion in 2024 to $25.24 billion in 2025 at a compound annual growth rate (CAGR) of 14.1%. The growth in the historic period can be attributed to aging population, regulatory compliance, infection control, materials for implants, tissue engineering.
The medical engineered materials market size is expected to see rapid growth in the next few years. It will grow to $43.18 billion in 2029 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to global health preparedness, 3D printing and additive manufacturing, advanced coatings, nanomedicine, personalized medicine. Major trends in the forecast period include nanotechnology, biodegradable and resorbable materials, bioactive and smart materials, sustainability and eco-friendly materials, advancements in medical technology.
The forecast of 14.4% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through increased duties on biocompatible titanium and polyether ether ketone (PEEK) polymers from Switzerland, slowing the production of implants and prosthetics while driving up healthcare costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The anticipated increase in chronic diseases is poised to propel the growth of the medical engineered materials market. Chronic diseases, characterized by lasting a year or more and requiring ongoing medical attention or limiting daily activities, are driving the demand for materials that can be engineered at the nano level. Nanoengineered components are utilized to construct miniature replicas of heart chambers, offering innovative solutions for treating heart-related issues. As indicated by the National Center for Biotechnology Information (NCBI) in January 2023, the global population with chronic diseases is projected to reach 142.66 million by 2050, a significant rise from 71.522 million in 2020. Hence, the escalating instances of chronic diseases serve as a catalyst for the growth of the medical engineered materials market.
The increasing number of surgical procedures is expected to be a driving force behind the growth of the medical engineered materials market. Surgical procedures involve medical interventions that necessitate incisions or invasive techniques to access and treat internal or external body areas. This surge in surgical procedures creates a heightened demand for materials used in surgical instruments, implantable devices, and minimally invasive procedures. The critical need for biocompatible and infection-resistant materials underscores their role in ensuring patient safety. Research and development driven by customization and regulatory standards, coupled with innovations in materials prompted by cost efficiency and technological advancements, contribute to the growth of the medical engineered materials market. For example, the Organization for Economic Co-operation and Development reported an 8.4% increase in cataract surgical procedures in the Czech Republic in October 2023, totaling 142,670 procedures in 2022 compared to 131,612 in 2021. Therefore, the rising number of surgical procedures acts as a growth driver for the medical engineered materials market.
Major players in the medical engineered materials market are strategically introducing new products to enhance their competitive position. An instance of this is Celanese Corporation, a US-based specialty materials company, launching Celanex MT PBT 2406MT GF20 in May 2022. This high-performance material is tailored for medical devices and various applications, offering exceptional strength, stiffness, and noise-free sliding capabilities. It finds applicability in Class I, Class II, and Class III medical device applications, as well as in automotive, electrical, electronics, industrial machinery, and consumer goods. The tribologically modified PBT+PET grade, reinforced with 20% glass fiber, provides versatile solutions across multiple industries.
Major companies in the medical engineered materials market are investing in the development of new products to gain a competitive edge. Covestro AG, a Germany-based polymer materials company, introduced Makrolon 3638 polycarbonate in February 2023. This advanced material solution, tailored for healthcare and life sciences applications, exhibits high durability across a wide temperature range, from cryogenic to steam sterilization conditions. It features high impact strength and ductility, along with high chemical resistance, meeting medical-grade and biocompatibility standards. Suitable for skin contact applications, the material is also of food contact quality and can be sterilized using common methods in the healthcare sector.
In February 2022, Celanese Corporation, a US-based global chemical leader, completed the acquisition of DuPont's resins and Advanced Solutions business lines for $11 billion. This strategic move is expected to position Celanese as a market leader with unparalleled scale, production capabilities, and technological expertise to cater to the automotive, consumer, and industrial markets. DuPont, a US-based company operating in medical engineered materials, is part of this acquisition.
Major companies operating in the medical engineered materials market include Evonik Industries AG, Covestro AG, BASF SE, Solvay SA, Saudi Basic Industries Corporation, Trelleborg AB, Koninklijke DSM N.V, Celanese Corporation, DuPont de Nemours Inc., Ethicon Inc., Henkel AG & Co. KGaA, Huntsman Corporation, Momentive Performance Materials Inc., Nitto Denko Corporation, Recticel Ltd., Victrex plc, Ensinger GmbH, RTP Company, Foster Corporation, Zeus Industrial Products Inc., Saint-Gobain SA, Arkema SA, Eastman Chemical Company, Lubrizol Corporation, PolyOne Corporation, Quadrant AG, Rochling Group, DSM Biomedical, Invibio Ltd., Carpenter Technology Corporation, Heraeus Medical Components GmbH, CeramTec GmbH, Morgan Advanced Materials plc, Freudenberg Medical LLC, Synectic Engineering Inc., Medtronic plc, Abbott Laboratories, Johnson & Johnson, Siemens Healthineers AG
Asia-Pacific was the largest region in the medical engineered materials market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this medical engineered materials market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
The countries covered in the medical engineered materials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
The medical engineered materials market consists of sales of medical plastics, medical foams, medical films, medical elastomers, and medical adhesives. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Medical Engineered Materials Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on medical engineered materials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for medical engineered materials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical engineered materials market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.